GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Total Stockholders Equity

U-Neuron Biomedical (ROCO:6973) Total Stockholders Equity : NT$491.97 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Total Stockholders Equity?

U-Neuron Biomedical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$491.97 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. U-Neuron Biomedical's Book Value per Share for the quarter that ended in Dec. 2023 was NT$16.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. U-Neuron Biomedical's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.02.

U-Neuron Biomedical Total Stockholders Equity Historical Data

The historical data trend for U-Neuron Biomedical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Total Stockholders Equity Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
68.97 195.44 163.27 491.97

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity 195.44 - 163.27 522.29 491.97

U-Neuron Biomedical  (ROCO:6973) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

U-Neuron Biomedical's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(491.967-0)/29.55
=16.65

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

U-Neuron Biomedical's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4.767 + 4.896) / 491.967
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines